Archives

by in
Entry Author Date Location
Backed by Gates, Affinivax Ramps up Velcro-like Vaccine Tech 10/30/14 Boston
Engaged Learning, Backed by Gates Foundation, Adapts to Each Student 05/20/14 Seattle
Seattle Roundup: Tidal Turbine, IDRI, Tango Card, Codementor, TAGS 04/04/14 Seattle
Seattle BioMed Nabs $10M NIAID Grant to Develop HIV Vaccines 03/10/14 Seattle
East Coast Biotech Roundup: Scholar Rock, Dicerna, Eleven, & More 01/03/14 Boston
IDRI CEO Stewart Parker Steps Down, Erik Iverson Steps Up 12/19/13 Seattle
Seattle Startup Koru Takes On Tech Training, Hiring for Recent Grads 12/18/13 Seattle
Gates Foundation Gets UCSF Chief Desmond-Hellmann as New CEO 12/17/13 Seattle
What Was Hyped, and What Fell Out of Favor, This Year in Biotech 12/16/13 National
Building Biotechs to Last: See the Agenda for Monday 12/05/13 San Francisco
Visterra Adds $8M, Ex-Amag Execs, To Begin Clinical Push for Flu Antibody 12/02/13 Boston
Visterra Obtains $8,100,000 Series A Financing 12/02/13 Boston
San Diego Life Sciences Roundup: Orexigen, Avalon, GSK, and More 11/27/13 San Diego
Gates Foundation Health Chief on Coaxing Pharma to Do Good (Part 2) 11/26/13 National
Gates Foundation Health Chief on Coaxing Pharma to Do Good 11/25/13 National
Look Who’s Hiring in Biotech: Companies That Are Built to Last 11/21/13 San Francisco
Building Biotechs to Last: A Sneak Peek at the Agenda for Dec. 9 11/19/13 San Francisco
Lessons from the St. Louis Cardinals and ‘Building Biotechs to Last’ 10/30/13 San Francisco
Profiles in Perseverance: Building Biotechs to Last. Coming Dec. 9 10/18/13 San Francisco
Wave of Capital for Ed-Tech Startups Kairos, LearnBIG, Actively Learn 10/03/13 Seattle
Don’t Be Naïve: 7 Things to Know Before Taking a Biotech Startup Job 09/16/13 National
Roundup: Raikes Leaving Gates Foundation; Front Desk, Versium Funding 09/10/13 Seattle
From Assets to Zen: Building Successful Drug Hunting Relationships 04/22/13 San Diego
Sequencing Seattle: An Idea for the Future of the Northwest 04/03/13 Seattle
Gates Foundation Invests in Flu Drug Developer Visterra 11/09/12 Boston
Visterra Obtains $13,000,000 Series A Financing 11/09/12 Boston
The New Power Players in Drug R&D Are Wearing Bright T-Shirts 10/29/12 National
Inigral Lands $3,250,000 New Funding 10/17/12 San Francisco
Genocea Snags $30M from Gates Foundation, VCs for New Vaccines 10/10/12 Boston
Genocea Biosciences Secures $30,000,000 Series C Financing 10/10/12 Boston
Page 1 of 5 next page »